Quick Answer
Organon & Co. reported Diluted EPS of $0.72 per share for fiscal year 2025.
Organon & Co. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.72 | -78.4% |
| 2024 | $3.33 | -16.5% |
| 2023 | $3.99 | +11.1% |
| 2022 | $3.59 | -32.4% |
| 2021 | $5.31 | -37.7% |
| 2020 | $8.52 | -32.9% |
| 2019 | $12.69 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.61 | -55.8% | +8.9% |
| June 30, 2025 | $0.56 | -25.3% | +69.7% |
| March 31, 2025 | $0.33 | -57.7% | -76.1% |
| September 30, 2024 | $1.38 | +500.0% | +84.0% |
| June 30, 2024 | $0.75 | -21.1% | -3.8% |
| March 31, 2024 | $0.78 | +13.0% | +239.1% |
| September 30, 2023 | $0.23 | -74.2% | -75.8% |
| June 30, 2023 | $0.95 | +3.3% | +37.7% |
- Organon & Co. showed a decrease of -78.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Organon & Co.’s diluted eps has declined by 94.3% (from $12.69 per share to $0.72 per share).
- The most recent figure is from Organon & Co.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: